Zilebesiran is an investigational new drug developed by Roche and Alnylam that is being evaluated for the treatment of high blood pressure. From Wikipedia
The KARDIA-2 results in JAMA pave the way for trials to assess effects on heart attacks, strokes and cardiovascular death.
